260 related articles for article (PubMed ID: 27721611)
1. Human MutL homolog 1 immunoexpression in oral leukoplakia and oral squamous cell carcinoma: A prospective study in Indian population.
Chaudhari NT; Tupkari JV; Joy T; Ahire MS
J Oral Maxillofac Pathol; 2016; 20(3):453-461. PubMed ID: 27721611
[TBL] [Abstract][Full Text] [Related]
2. hMLH1 immunoexpression is related to the degree of epithelial dysplasia in oral leukoplakia.
Caldeira PC; Abreu MH; Batista AC; do Carmo MA
J Oral Pathol Med; 2011 Feb; 40(2):153-9. PubMed ID: 20969633
[TBL] [Abstract][Full Text] [Related]
3. An immunohistochemical evaluation of podoplanin expression in oral leukoplakia and oral squamous cell carcinoma to explore its potential to be used as a predictor for malignant transformation.
Aiswarya A; Suresh R; Janardhanan M; Savithri V; Aravind T; Mathew L
J Oral Maxillofac Pathol; 2019; 23(1):159. PubMed ID: 31110440
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical expression of budding uninhibited by benzimidazole related 1 in leukoplakia and oral squamous cell carcinoma.
Sravya T; Sivaranjani Y; Rao GV
J Oral Maxillofac Pathol; 2016; 20(1):71-7. PubMed ID: 27194865
[TBL] [Abstract][Full Text] [Related]
5. Computer-Assisted Morphometric Comparative Analysis of Argyrophilic Nucleolar Organizer Regions (AgNORs) in Leukoplakia With Dysplasia and Oral Squamous Cell Carcinoma.
Nararyanan RC; Sebastian BT; Sulaikha SH; Augustine C; Thomas T; Sudhakaran A
Cureus; 2024 Feb; 16(2):e54471. PubMed ID: 38510852
[TBL] [Abstract][Full Text] [Related]
6. Increased VEGFR2 and MMP9 protein levels are associated with epithelial dysplasia grading.
de Carvalho Fraga CA; Farias LC; de Oliveira MV; Domingos PL; Pereira CS; Silva TF; Roy A; Gomez RS; de Paula AM; Guimarães AL
Pathol Res Pract; 2014 Dec; 210(12):959-64. PubMed ID: 25441661
[TBL] [Abstract][Full Text] [Related]
7. Immunoexpression of hMSH2 and hMLH1 in oral squamous cell carcinoma and its relationship to histological grades of malignancy.
Fernandes AM; Ramos-Jorge ML; Cardoso SV; Loyola AM; Mesquita RA; Aguiar MC
J Oral Pathol Med; 2008 Oct; 37(9):543-8. PubMed ID: 18331286
[TBL] [Abstract][Full Text] [Related]
8. MLH1, MSH2, MRE11, and XRCC1 in Oral Leukoplakia and Oral Squamous Cell Carcinoma.
Donís SP; González AP; Alves MGO; do Carmo Carvalho BF; Ferreira CCP; Almeida JD; Iruegas EP; Petronacci CMC; Peñaranda JMS; Sayáns MP
Appl Immunohistochem Mol Morphol; 2021 Sep; 29(8):613-618. PubMed ID: 33734109
[TBL] [Abstract][Full Text] [Related]
9. TWIST and p-Akt immunoexpression in normal oral epithelium, oral dysplasia and in oral squamous cell carcinoma.
Silva BS; Yamamoto FP; Pontes FS; Cury SE; Fonseca FP; Pontes HA; Pinto-Júnior DD
Med Oral Patol Oral Cir Bucal; 2012 Jan; 17(1):e29-34. PubMed ID: 21743395
[TBL] [Abstract][Full Text] [Related]
10. MutSα and MutLα immunoexpression analysis in diagnostic grading of oral epithelial dysplasia and squamous cell carcinoma.
Jessri M; Dalley AJ; Farah CS
Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Jan; 119(1):74-82. PubMed ID: 25446502
[TBL] [Abstract][Full Text] [Related]
11. The combination of SMAD4 expression and histological grade of dysplasia is a better predictor for the malignant transformation of oral leukoplakia.
Xia RH; Song XM; Wang XJ; Li J; Mao L
PLoS One; 2013; 8(6):e66794. PubMed ID: 23826135
[TBL] [Abstract][Full Text] [Related]
12. Demographic study of 366 cases of oral leukoplakia and immunohistochemical analysis - An institutional study.
Ahire MS; D Souza ZI; Chettiankandy TJ; Nagar SR; Sinha A; Tupkari JV
J Oral Maxillofac Pathol; 2021; 25(3):478-484. PubMed ID: 35281146
[TBL] [Abstract][Full Text] [Related]
13. Oral leukoplakias with different degrees of dysplasia: comparative study of hMLH1, p53, and AgNOR.
Caldeira PC; Aguiar MC; Mesquita RA; do Carmo MA
J Oral Pathol Med; 2011 Apr; 40(4):305-11. PubMed ID: 21208285
[TBL] [Abstract][Full Text] [Related]
14. Role of bcl-2 oncoprotein in oral potentially malignant disorders and squamous cell carcinoma: an immunohistochemical study.
Sudha VM; Hemavathy S
Indian J Dent Res; 2011; 22(4):520-5. PubMed ID: 22124045
[TBL] [Abstract][Full Text] [Related]
15. Expression of mucin-1 in oral squamous cell carcinoma and normal oral mucosa: An immunohistochemical study.
Thakur A; Tupkari JV; Joy T; Kende PP; Siwach P; Ahire MS
J Oral Maxillofac Pathol; 2018; 22(2):210-215. PubMed ID: 30158774
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of salivary MMP-9 in oral squamous cell carcinoma and oral leukoplakia using ELISA.
Pazhani J; Chanthu K; Jayaraman S; Varun BR
J Oral Maxillofac Pathol; 2023; 27(4):649-654. PubMed ID: 38304520
[TBL] [Abstract][Full Text] [Related]
17. A Comparative Study of Morphometric Analysis of Nucleolar Organizer Regions in Oral Leukoplakia and Oral Squamous Cell Carcinoma and Significance of AgNOR as a Diagnostic Tool.
Singh A; Singh S; Soni V; Srivastava DK
Cureus; 2023 Aug; 15(8):e44228. PubMed ID: 37772250
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of Epstein-Barr virus-encoded latent membrane protein-1 (LMP-1) in oral squamous cell carcinoma.
Rahman R; Poomsawat S; Juengsomjit R; Buajeeb W
BMC Oral Health; 2019 Jul; 19(1):142. PubMed ID: 31291930
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of human mutL homolog 1 and mutS homolog 2 genes in head and neck squamous cell carcinoma tumors and leukoplakia samples by promoter hypermethylation and its relation with microsatellite instability phenotype.
Sengupta S; Chakrabarti S; Roy A; Panda CK; Roychoudhury S
Cancer; 2007 Feb; 109(4):703-12. PubMed ID: 17219447
[TBL] [Abstract][Full Text] [Related]
20. Epithelial and fibroblast SPARC expression patterns in oral leukoplakia and oral squamous cell carcinoma.
Poomsawat S; Kosanwat T; Meesakul O; Sanguansin S
Oral Surg Oral Med Oral Pathol Oral Radiol; 2022 Aug; 134(2):e44-e50. PubMed ID: 35165061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
